There are various versions of the openEHR logo in use as shown below.
Please adhere to our Logo Usage Policy.
Specification for font
Soehne Breit
Specification for colours
Orange: RGB = 255, 134, 28 [#FF861C]; HSV = 28, 89, 100
Blue: RGB = 37, 139, 176 [#258BB0]; HSV = 196, 79, 69
| Technical specification | |
|---|---|
 | PNG (513×90) |
 | PNG (263×192) |
 | PNG 150x |
 |
Use of openEHR trademarks
This application is for Product Use of the openEHR trademarks. It is intended for when organisations make use of the openEHR trademarks beyond fair use, including in company advertising material, product names, and domain URLs, but not including events. For events, see the Community Use License. Note: if you have questions about how to fill in this licence agreement, or about the openEHR Trademark policy, please contact comms@openEHR.org.
Use of the term “openEHR” must include the Registered trademark symbol at least once per screen or page i.e. “openEHR®“. The following text must also be clearly visible on any website or in documentation “openEHR® is the registered trademark of the openEHR Foundation and is used with the permission of openEHR International. Use of the trademark does not constitute endorsement of this product by openEHR International or openEHR Foundation.”
This Product Use Licence (the “Agreement”) governs the use of openEHR International’s (“openEHR”) openEHR trademark by “Licensee” (see below), together with openEHR, the “Parties”. By applying, the Licensee agrees, subject to openEHR’s acceptance, to be bound by this Agreement with openEHR if openEHR provides to Licensee its written acceptance.
The person applying represents and warrants on behalf of licensee that s/he is authorised to sign contracts on behalf of, and to thereby bind, licensee.
After you apply, this agreement remains subject to openehr’s acceptance. no contract is formed hereby, and licensee is not authorised to use the proposed alternate usage or the openehr mark pursuant to this agreement until licensee has received written acceptance from openehr, the date of which acceptance shall be the “effective date”. openehr will use reasonable efforts to respond to this request for a licence within thirty (30) days of the date licensee has submitted its request for a licence.
Whereas, openEHR owns all right, title, and interest in and to the openEHR trademark, registered with the U.S. Patent & Trademark Office (U.S. Reg. No. 4,272,380) (the “openEHR Mark”); EU EUIPO (Reg 002994853) and IP Australia (Reg 939279).
Whereas, openEHR wishes to grant, and Licensee wishes to receive, a licence to the above mark in connection with the Authorised Goods/Services below.
Now therefore, for good and sufficient consideration, the receipt of which is acknowledged hereby, the parties agree as follows subject to the terms and conditions attached hereto
Organisation:
The Organisation that is applying for a community use licence
Contact Email Address:
The contact email for further communication about this community licence agreement
Country / Region / “Global”:
The country (or other legal entity) in which the community use applies. If the use covers more than one country, provide a region (e.g. Europe) or “global”
Add Product to Registry?
Please inform us if you want the product to be considered for addition to the public registry of openEHR applications.
Description:
A description of proposed usage – please describe how the use of the openEHR trademark contributes to the overall product, and ensure that the proposed use clearly describes how the product usage of openEHR is clearly ‘an application of openEHR’ rather than ‘the openEHR standard itself’
Steps Taken to Ensure Product is Consistent with the openEHR specification:
Please describe what steps you have taken to ensure the product and its openEHR usage is conformant with the openEHR specification. Note: this is not asking whether your use of the trademarks is conformant with the trademark use request, but how you ensure that the products/services you offer are conformant/consistent with the openEHR specification. If the application is for a domain name, then answer what process you use to ensure that the domain content is consistent with the openEHR specification.
Please read and understand the following sections before applying.
1.1. Subject to the terms of this Agreement, openEHR grants to Licensee the non-exclusive right in the Territory to use the openEHR wordmark (the “Mark”) in connection with the Authorised Goods/Services only (such use a “Licensed Use”). The foregoing licence does not include the right to sublicense.
1.2. Licensee shall use the ® symbol after the openEHR Mark e.g openEHR®“. The following text must also be clearly visible on any website or in documentation “openEHR® is the registered trademark of the openEHR Foundation and is used with the permission of openEHR International. Use of the trademark does not constitute endorsement of this product by openEHR International or openEHR Foundation.”
1.3. All goodwill arising from or relating to Licensee’s use of the Mark shall inure to the benefit of openEHR. To the extent any right, title, or interest to the Mark are deemed to accrue to Licensee pursuant to this Agreement or otherwise, Licensee shall and hereby does assign any and all such right, title, and interest (and all goodwill arising from or relating to any of them) to openEHR.
1.4. Licensee shall only exercise the licence granted herein with Licensed Uses approved by openEHR. If openEHR has not delivered to Licensee its written rejection of such proposed Licensed Use within ten (10) days after receipt, then approval is deemed to have been given. Licensee shall, promptly upon openEHR’s request, deliver to openEHR representative samples of Licensed Uses and shall cease any Licensed Uses that do not meet openEHR’s approval. Licensee shall not use any unlicensed derivative of the Mark without openEHR’s prior written consent and approval.
1.5. Licensee shall maintain the highest quality and standards of the Licensed Uses and shall safeguard the established prestige and goodwill in the Mark at the same level of prestige and goodwill previously held and maintained by openEHR. Licensee shall ensure that its performance of the Authorised Goods/Services are of high quality and in conformity with high industry standards. Licensee shall promptly upon openEHR’s request provide openEHR with information regarding the Licensed Uses.
1.6. Licensee agrees and acknowledges that openEHR is the owner of all rights, title, and interest in and to the Mark. Licensee shall neither (i) challenge the validity of openEHR’s ownership of the Mark; nor (ii) contest the fact that Licensee’s rights under this Agreement and its right to use the Mark terminates upon termination of this Agreement.
2.1. The initial term of this Agreement will begin on the Effective Date and shall end on the first December 31 thereafter. This Agreement shall automatically renew for successive one (1) year terms provided that neither party has provided the other party with notice of termination at least thirty (30) days before the end of the then-current term. Sections 1.4 and 1.7, and Articles 2, 4, and 5 shall survive termination of this Agreement.
2.2. openEHR may terminate this Agreement on Licensee’s breach, which breach remains uncured ten (10) days after written notice thereof. Licensee shall cease and desist all trademark usage of the Mark immediately upon Agreement termination.
Infringement
3.1. Licensee shall provide prompt written notice to openEHR of any infringement of the Mark by third parties, or any act of false suggestion of affiliation or sponsorship relating to the Licensed Uses, or any act of false suggestion of affiliation or sponsorship by third parties relating to the Mark, whenever such infringement or act comes to Licensee’s attention.
4.1. The mark is licensed hereby “as is” without warranty, express or implied of any kind, including but not limited to the implied warranties of merchantability and fitness for a particular purpose. the entire risk arising out of the use of the mark remains with licensee. licensee acknowledges and agrees that it has not relied on any express or implied representation of discreet, written or oral, as an inducement to entering into this agreement.
4.2. In no event will openEHR be liable to the other for any special, indirect, incidental, punitive, exemplary or consequential damages in any way arising out of or in connection with this agreement, even if openEHR has been made aware of the possibility of such damages.
4.3. openEHR’S aggregate, cumulative liability for any and all claims arising out of or in connection with the mark or this agreement shall be limited to direct damages in the amount equivalent to the fees actually received by openEHR from licensee hereunder. the limitations and exclusions set forth in this section apply to all claims or causes of action on whatever basis and under whatever theory brought and irrespective of whether openEHR has been advised of the possibility of such claim or damages. These limitations will apply notwithstanding any failure of essential purpose of any limited remedy.
4.4. Each party represents and warrants that (i) it has the authority to enter into this Agreement and to perform its obligations hereunder; and (ii) to their respective knowledge as of the Effective Date, Licensee’s exercise of the rights granted hereunder shall not violate the rights of any third party, including without limitation, rights in trademark, unfair competition, and contract.
5.1. All reports, communications, requests or notices required by or permitted under this Agreement will be in writing and will be deemed to be duly given on the date the same is electronically delivered, hand-delivered and acknowledged or, if mailed, when mailed by certified or registered mail, return receipt requested, to the party’s addresses identified above. Either party may change the address to which such notices and communication will be sent by written notice to the other party, provided that any notice of change of address will be effective only upon receipt. Notwithstanding anything to this Section 5.1 to the contrary, Licensee shall send a contemporaneous copy of any and all written communication to openEHR hereunder to at comms@openeehr.org or such other email address as openEHR shall from time to time direct.
5.2. This Agreement may be assigned by Licensee only with the prior written consent of openEHR. openEHR may assign this Agreement without restriction. Any attempted assignment in contravention of this Section 5.2 will be null, void, and without effect.
5.3. This Agreement will be governed by and construed in accordance with the laws of the United Kingdom, without regard to its choice of law provisions. The parties shall file and prosecute any and all litigation arising from or relating to the Mark or this Agreement before any court of competent subject matter jurisdiction in the United Kingdom. The parties hereto consent to the exclusive jurisdiction of such courts over them, stipulate to the convenience, efficiency and fairness of proceeding in such courts, and covenant not to allege or assert the inconvenience, inefficiency, or unfairness of proceeding in such courts.
5.4. This Agreement does not create a partnership or joint venture between the parties.
5.5. This Agreement is formed by Licensee’s submitting the application form here
5.6. This Agreement constitutes the entire agreement between Licensee and openEHR with respect to the subject matter contained herein, and supersedes and terminates any prior agreements, proposals or understandings relating to such subject matter. No addendum, consent, modification, amendment or change of the terms of this Agreement will bind either party unless made in writing and signed by the parties.
5.7. No waiver by either party of any breach hereunder shall be effective unless given in writing, nor shall any such waiver be deemed a waiver of any other breach.
5.8. In the event of any litigation regarding this Agreement, openEHR, in the event it is the prevailing party as determined by the appropriate court, shall be entitled to recover its actual attorneys’ fees and costs arising from or relating to the litigation itself and investigations arising therefrom or relating thereto.
5.9. In the event that any provision of this Agreement is held by a court of competent jurisdiction to be unenforceable because it is invalid or unenforceable, the validity and enforceability of the remaining provisions will not be affected, and the invalid or unenforceable provision shall be automatically revised so as to be valid and enforceable and to as nearly as possible reflect the intent of the parties.